GALT EFFECT SEC Filing Analysis

Latest settled — T+20d

GALT ▼ -5.96% at T+20d

NEUTRAL call ✗ call lost -5.96% · α vs SPY -13.69% · entry $2.35 → $2.21

Next anchor: T+60d in 6w

Last close $2.50 (close May 22) · +6.38% from $2.35 entry

Entry anchored
Apr 10, 03:59 PM ET
via Databento tick

T+1d

+5.11%

call +5.11% · α +3.90%

$2.47

settled 6w ago

T+5d

-2.55%

call -2.55% · α -5.85%

$2.29

settled 5w ago

T+20d

-5.96%

call -5.96% · α -13.69%

$2.21

settled 13d ago

T+60d

—

call — · α —

—

in 6w

Price Chart

Loading chart...

Executive Summary

Galectin Therapeutics' shelf registration (Form S-3) has become effective, allowing the company to raise up to $200 million through future sales of common stock, warrants, or rights. This includes a pre-arranged $32.5 million at-the-market (ATM) offering program.

Actionable Insight

Monitor for future prospectus supplements indicating actual sales under the shelf or ATM program, which could lead to near-term dilution. The effectiveness itself does not raise capital but enables future offerings.

Key Facts

Shelf registration Form S-3 (File No. 333-294782) became effective on April 10, 2026.
Allows issuance of up to $200 million in common stock, warrants, and rights over time.
Includes a $32.5 million ATM program with H.C. Wainwright & Co. established on May 11, 2020.
No immediate fundraising; securities may be offered continuously or intermittently based on market conditions.

Financial Impact

Up to $200 million in potential future dilution; up to $32.5 million available immediately via ATM.

dilutionequitycash

Risk Factors

Potential share dilution if offerings proceed under the shelf or ATM program.
Market perception of equity overhang may pressure the stock despite no immediate issuance.

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

Document	Accession Number
EFFECT Filing (Primary)	9999999995-26-001150
Document: 9999999995-26-001150-index.html	9999999995-26-001150
Document: 9999999995-26-001150.txt	9999999995-26-001150

4 reports for GALT

T+1T+5T+20T+60

Filters

Reports for GALT — sortable, filterable
	Type				Now
May 15, 2026 8d ago	Press Release BULLISH ★ 6/10	$2.36 awaiting T+20	awaiting T+20	—	$2.50 (+5.93%)
May 15, 2026 8d ago	8-K NEUTRAL ★ 5/10	—	awaiting T+20	—	—
Apr 13, 2026 5w ago	EFFECT NEUTRAL ★ 3/10	$2.35 $2.21	▼ −5.96%	▼ −13.69%	$2.50 (+6.38%)
Mar 31, 2026 7w ago	8-K MIXED ★ 6/10	$2.79 $2.28	▼ −18.28%	▼ −27.70%	$2.50 (−10.39%)

US Market Status

Market Closed — Opens Tue (34h 50m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access